The Role of Transcriptomics in Redefining Critical Illness.

Crit Care

Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW, Australia.

Published: March 2023

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2023. Other selected articles can be found online at  https://www.biomedcentral.com/collections/annualupdate2023 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from  https://link.springer.com/bookseries/8901 .

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027592PMC
http://dx.doi.org/10.1186/s13054-023-04364-2DOI Listing

Publication Analysis

Top Keywords

annual update
8
update intensive
8
intensive care
8
care emergency
8
emergency medicine
8
role transcriptomics
4
transcriptomics redefining
4
redefining critical
4
critical illness
4
illness article
4

Similar Publications

According to South Korea's Ministry of Employment and Labor, approximately 25,000 construction workers suffered from various injuries between 2015 and 2019. Additionally, about 500 fatalities occur annually, and multiple studies are being conducted to prevent these accidents and quickly identify their occurrence to secure the golden time for the injured. Recently, AI-based video analysis systems for detecting safety accidents have been introduced.

View Article and Find Full Text PDF

Evaluation of reporting trends in the MAUDE Database: 1991 to 2022.

Digit Health

January 2025

University of Haifa, School of Public Health, Head, Division of Health Systems Policy and Administration, Haifa, Israel.

Unlabelled: Adverse event reporting for medical devices is critical for risk mitigation. The Food and Drug Administration's (FDA) Manufacturer and User Facility Device Experience (MAUDE) database serves as a key tool for post-market surveillance, receiving reports from various sources. Ensuring information integrity, especially across diverse reporting sources, is paramount.

View Article and Find Full Text PDF

Background: Verbal autopsy (VA) has been a crucial tool in ascertaining population-level cause of death (COD) estimates, specifically in countries where medical certification of COD is relatively limited. The World Health Organization has released an updated instrument (Verbal Autopsy Instrument 2022) that supports electronic data collection methods along with analytical software for assigning COD. This questionnaire encompasses the primary signs and symptoms associated with prevalent diseases across all age groups.

View Article and Find Full Text PDF

Estimates of the burden of skin melanoma in Italy: update to 2024.

Ital J Dermatol Venerol

January 2025

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.

Background: The epidemiology of skin melanoma (SM) is rapidly changing. Therefore, we aimed at updating up to 2024 the Italian estimates on SM providing the number of incident and prevalent cases, the deaths and the distribution by stage at diagnosis.

Methods: Incidence was extrapolated from age- and sex-specific International Agency for Research on Cancer (IARC) estimates from 2022 to 2025.

View Article and Find Full Text PDF

LI-RADS Ultrasound Surveillance Version 2024: Comparison With Version 2017 for Hepatocellular Carcinoma Detection and Risk Factors for Visualization Score C.

AJR Am J Roentgenol

January 2025

Liver Imaging Group, Department of Radiology, UC San Diego, San Diego, California, United States of America.

The LI-RADS Ultrasound Surveillance algorithm was updated in 2024, incorporating alpha-fetoprotein (AFP) and visualization score of VIS-C into management recommendations after nonpositive results. This study aimed to compare the diagnostic performance of LI-RADS Ultrasound Surveillance version 2017 (v2017) and version 2024 (v2024) for hepatocellular carcinoma (HCC) detection in at-risk patients and to identify predictors of VIS-C on follow-up surveillance examinations. This retrospective analysis included 407 patients (median age, 56 years; 230 male, 177 female) with cirrhosis who underwent rounds of semi-annual surveillance ultrasound as part of a prospective trial from November 2011 to December 2012.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!